Home » Syndicated Content » OncoGenex plans to initiate OGX-42
Phase 2 trial in patients with advanced squamous cell lung cancerOncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, ...
[Published BioPortfolio - 9 hours ago]